U.S. Biopharmaceutical Third-party Logistics Market Is Likely To Up Demand At A USD 87.2 Billion By 2030
San Francisco, 2 Jan 2023: The Report U.S. Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service, By Product Type (Specialty Drug), And Segment Forecasts, 2022 - 2030 The U.S. biopharmaceutical third-party logistics market size is expected to reach USD 87.2 billion by 2030, expanding at a CAGR of 7.3% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for novel biologics and the need to manage those is boosting the market growth. Besides, rising demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the growth. The COVID-19 pandemic has had a major impact on global logistics to some extent due to diminished air freight capacity and reduced workforce at warehouses and airports. The decisions of local